2010
DOI: 10.1371/journal.pone.0011634
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a Novel Staphylococcus aureus Two-Component Leukotoxin Using Cell Surface Proteomics

Abstract: Staphylococcus aureus is a prominent human pathogen and leading cause of bacterial infection in hospitals and the community. Community-associated methicillin-resistant S. aureus (CA-MRSA) strains such as USA300 are highly virulent and, unlike hospital strains, often cause disease in otherwise healthy individuals. The enhanced virulence of CA-MRSA is based in part on increased ability to produce high levels of secreted molecules that facilitate evasion of the innate immune response. Although progress has been m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

11
211
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 188 publications
(222 citation statements)
references
References 56 publications
11
211
0
Order By: Relevance
“…Despite the lack of overlap in cellular targets identified thus far, the staphylococcal leukotoxins have been shown to exhibit synergistic effects (26). The identification of CD11b as a cellular target for LukAB provides an explanation for the previously reported synergism between LukAB and PVL toward human PMNs (10,11), as sublytic concentrations of PVL increase CD11b surface levels on these cells (27). From an evolutionary standpoint, the use of multiple, nonoverlapping cellular targets provides an explanation for why S. aureus has such a large arsenal of cytotoxins and is such a welladapted pathogen when it comes to evading host PMNs.…”
Section: Discussionmentioning
confidence: 96%
See 3 more Smart Citations
“…Despite the lack of overlap in cellular targets identified thus far, the staphylococcal leukotoxins have been shown to exhibit synergistic effects (26). The identification of CD11b as a cellular target for LukAB provides an explanation for the previously reported synergism between LukAB and PVL toward human PMNs (10,11), as sublytic concentrations of PVL increase CD11b surface levels on these cells (27). From an evolutionary standpoint, the use of multiple, nonoverlapping cellular targets provides an explanation for why S. aureus has such a large arsenal of cytotoxins and is such a welladapted pathogen when it comes to evading host PMNs.…”
Section: Discussionmentioning
confidence: 96%
“…A single S. aureus strain can produce up to five different leukotoxins including two versions of γ-hemolysin (HlgAB and HlgCB), leukocidin E/D (LukED), Panton-Valentine leukocidin (PVL), and leukocidin A/B (LukAB, also known as LukGH) (4)(5)(6). The sequence similarity among these leukocidins ranges from 60% to 80% with the exception of LukAB, which is only 30-40% similar to the others (9,10). LukAB is the most recently identified member of the bicomponent leukocidin family (9,10).…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…SaeRS regulates transcription of multiple toxins, including γ-toxin (hlgA, hlgB, hlgC), LukSF-PVL, and LukAB/LukGH, which have been shown to contribute to PMN lysis (26)(27)(28)(29)(30)(31). Additionally, transcription of the saePQRS operon and SaeR target genes are activated in response to PMN phagocytosis and PMN components (32)(33)(34).…”
Section: Mutagenesis Of the Predicted Extracellular Loop Of Saes Idenmentioning
confidence: 99%